{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:56:51Z","timestamp":1761541011756},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s6628","type":"journal-article","created":{"date-parts":[[2010,9,13]],"date-time":"2010-09-13T17:46:33Z","timestamp":1284399993000},"page":"127","source":"Crossref","is-referenced-by-count":8,"title":["Optimal use of recombinant factor VIIa in the control of bleeding episodes in hemophilic patients"],"prefix":"10.2147","author":[{"given":"John","family":"john puetz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2010,6]]},"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=6635","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:04:22Z","timestamp":1477850662000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/optimal-use-of-recombinant-factor-viia-in-the-control-of-bleeding-epis-peer-reviewed-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/dddt.s6628","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}